psoriatic psa treatment guideline

PsA Research Briefs: Comorbidities

Keep up-to-date on the latest psoriatic arthritis (PsA) research with our brief research summaries.

PsA May Put Liver at Risk

People with PsA may have an increased risk of liver disease, according to a new study that followed more than a million people for an average of 6 years. People with psoriasis were 37% more likely to develop liver disease than those without inflammatory diseases, the study found. Those with PsA were 38% more likely to have liver disorders. Taking methotrexate further increased their risk.

SOURCE: Journal of Investigative Dermatology, April 2018

Continue reading PsA Research Briefs: Comorbidities

psa research briefs comorbidities

PsA Research Briefs: Diabetes, Surgery, Fibromyalgia

Keep up-to-date on the latest psoriatic arthritis (PsA) research with our brief research summaries.

PsA Increases Diabetes Risk

Having PsA may increase your risk of diabetes, according to recent research. In a study of 1,305 PsA patients seen in a large specialty clinic between January 1978 and November 2014, Canadian researchers found their risk of developing diabetes was 43% higher than for the general population. The risk was greatest among those with the highest levels of PsA activity, suggesting inflammation may be a common thread in the two diseases.

Source: The Journal of Rheumatology, published online February 2017

Continue reading PsA Research Briefs: Diabetes, Surgery, Fibromyalgia

psoriatic arthritis research brief

Psoriatic Arthritis Research Briefs: Nail Changes, New Biologic, Biosimilar

Keep up-to-date on the latest psoriatic arthritis (PsA) research with our brief research summaries.

Nail Changes May Indi­cate Psoriatic Arthritis

Certain nail features can help doc­tors distinguish between psoriasis and psoriatic arthritis, and possibly lead to earlier or improved treatment for PsA, a new study suggests. In the analysis of 1,092 patients with either PsA or psoriasis only, researchers found that nail changes were more common among those with PsA than psoriasis only. Transverse (side-to-side) grooves, splinter hemorrhages (small broken blood vessels under the nails) and onycholysis (separation of the nail from the nail bed) were associated with arthritis. Transverse grooves were significantly associated with arthritis in the joint closest to the nail and enthesitis, inflammation where the tendons and ligaments insert into the bone.

Source: Journal of the American Academy of Dermatology, November 2017

Continue reading Psoriatic Arthritis Research Briefs: Nail Changes, New Biologic, Biosimilar

psoriatic arthritis research eye surgery

Psoriatic Arthritis Research Briefs: Disease Burden, Eye Surgery, New Biologic

Keep up-to-date on psoriatic arthritis (PsA) research with our brief research summaries.

Enthesitis and Dactylitis Associated With Greater Disease Burden

The presence of dactylitis – inflammation of the fingers and/or toes – and enthesitis – inflammation of the sites where the tendons or ligaments insert into the bone – can have important implications for people with PsA. A study of 1,567 PsA patients found that, overall, those with dactylitis or enthesitis had greater disease activity.

Additionally those with enthesitis had worse functional status, reported more pain and fatigue and were more likely to have work impairment. The study’s authors say their findings underscore the importance of identifying, assessing and managing enthesitis and dactylitis in people with PsA.

Source: Arthritis Care & Research, April 2017

Continue reading Psoriatic Arthritis Research Briefs: Disease Burden, Eye Surgery, New Biologic

psoriatic psa treatment guideline

An Early Look at the New Psoriatic Arthritis Treatment Guideline

Physicians will soon have a new guideline for the management of psoriatic arthritis (PsA). This ambitious undertaking, the details of which were presented recently at the American College of Rheumatology (ACR) Annual Meeting, involved a large panel of experts who analyzed and synthesized the best available evidence to create and support the recommendations.

The proposed guideline – which contains approximately 80 recommendations – will undergo final review prior to consideration for publication in 2018 in the journals Arthritis Care & Research and Arthritis & Rheumatism. It will help rheumatologists select treatments for their psoriatic arthritis patients based on the best available evidence, especially in light of all the new treatments recently approved for PsA by the Food and Drug Administration (FDA).

Continue reading An Early Look at the New Psoriatic Arthritis Treatment Guideline